Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

strating a clinical benefit, such as improvement in disease-related symptoms or increased survival

Important Safety Information(1)

Severe (NCI Grades 3/4) lab abnormalities (400 mg/day; 600 mg/day)- including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia (0%; 1%), and hepatotoxicity (6%; 8%)-and severe adverse experiences (NCI Grades 3/4), including severe fluid retention (eg, pleural effusion or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%), and musculoskeletal pain (6%; 1%) were reported among patients receiving Gleevec

Some patients (5%) were reported to have severe GI bleeds and/or intratumoral bleeds. GI tumor sites may have been the source of GI bleeds

Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and gastrointestinal (GI) perforation

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other comorbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction

Dose adjustments ma
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... , the company,s vice president of operations, was granted an ... at a per share exercise price of $0.43, the closing ... granted pursuant to Cardica, Inc.,s Inducement Plan, which was approved ... Rule 5653(c)(4) of the Nasdaq Global Market for equity grants ...
(Date:5/21/2015)... May 21, 2015 The Pharmaceutical Care ... the Medicare Part D offsets included in the ... "If the 21st Century Cures initiative can ... premier health program – Medicare – then its ... down the road. "Leveraging payments to ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Cardica Announces New Employment Inducement Grant 2
... 22, 2011 Prasco Laboratories, the Authorized Generics company, ... Shionogi Inc . Under the terms of the ... Nitrofurantoin Oral Suspension, the Authorized Generic version of Furadantin® Oral ... U.S. under the Prasco label. "Prasco is ...
... ("MGT", "we", or "the Company") (AMEX: MGT ), a ... following update on recent developments at the Company and its majority-owned ... a summary of its recently filed financial results (via SEC Form ... 2011. Highlights: On ...
Cached Medicine Technology:Prasco® Launches Authorized Generic with Shionogi Inc. 2MGT Capital Investments, Inc. Provides Update on Recent Developments 2MGT Capital Investments, Inc. Provides Update on Recent Developments 3MGT Capital Investments, Inc. Provides Update on Recent Developments 4MGT Capital Investments, Inc. Provides Update on Recent Developments 5MGT Capital Investments, Inc. Provides Update on Recent Developments 6
(Date:5/22/2015)... Mountain Point Medical Center, a campus of Jordan Valley Medical ... 29, 2015 at 11 a.m., followed by a community celebration ... set to officially open on June 1, 2015, is located ... “The opening of Mountain Point Medical Center is an exciting ... Kent Loosle, CEO of Mountain Point Medical Center. “Mountain Point ...
(Date:5/22/2015)... NS (PRWEB) May 22, 2015 Following ... a sale agreement with US-based health brand Nature’s Way, ... Skin brand. Retention of Ascenta Skin is an integral ... is excited about this opportunity to further develop Ascenta ... , Ascenta Skin is a breakthrough, anti-aging skincare ...
(Date:5/22/2015)... Island, NY (PRWEB) May 22, 2015 ... announces that June 17, 2015, the Annual One Day ... place. Since 2007, Hands On HCMT offers drastically reduced certificates ... therapists and estheticians have enough sessions, through what used to ... it is wonderful for the community as well. This once ...
(Date:5/22/2015)... 22, 2015 Carnegie Science Center ... announced a new partnership to develop BodyTech, a dynamic, ... The initiative includes a new exhibit at the Science ... theater, and a new traveling science show, Anatomy Adventure, ... 2015. , Designed to explore a wide range ...
(Date:5/22/2015)... According to a new Aegis Living Study ... as likely to worry about what will happen to their ... Boomers, 69% Silent Generation), which may help explain why nearly ... aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). ... 2015 among more than 2,000 U.S. adults ages 18+. ...
Breaking Medicine News(10 mins):Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3
... dangerous characteristics of cancer is its ability to metastasize, or ... major need for better tests to detect cells that break ... the body. Effective identification of these cells, referred to ... improve quality of life for many cancer patients. A commentary ...
... 16, 2010 The AIUM is pleased to ... AIUM to endorse the recent AIUM Training Guidelines ... guidelines allow for a several practitioners, including physicians, ... ultrasound examinations, marking significant promise for the future ...
... ... Healthcare, 89 percent of physicians agree that patients receiving negligent treatment deserve fair compensation. ... Alpharetta, GA (Vocus) March 16, ... of physicians agree that patients receiving negligent treatment deserve fair compensation. , , , , ...
... Many with severe peripheral arterial disease can avoid amputation, ... When angioplasty fails, patients with severe peripheral arterial disease ... placed in the blocked artery below the knee might ... limb ischemia, the most severe form of peripheral arterial ...
... taking Plavix before surgery died soon after than those ... (HealthDay News) -- In a trial comparing two anti-clotting ... less likely to die than those given Plavix, researchers ... forming clots, but Plavix, the more popular drug, has ...
... President and CEO Dr. Richard Merkin , was featured on several segments throughout the day on Fox National News and Fox Business Channel discussing current healthcare payment structures ... ... ... ...
Cached Medicine News:Health News:Revisiting the need to detect circulating tumor cells 2Health News:Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 3Health News:Stenting May Save Legs 2Health News:Stenting May Save Legs 3Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 2Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 3Health News:Lakeside Medical Group, Heritage Provider Network, CEO Dr. Richard Merkin, Featured on Several Segments of Fox National News and Fox Business Channel on Current Healthcare Payment Structures to Physicians 2Health News:Lakeside Medical Group, Heritage Provider Network, CEO Dr. Richard Merkin, Featured on Several Segments of Fox National News and Fox Business Channel on Current Healthcare Payment Structures to Physicians 3
... Post Operative Pin® Knee Brace (DxHDDLP) has a ... drop lock lever and laminate liner. The precision ... brace from migrating on the leg during ambulation. ... that controls flexion and extension in 5° increments ...
... Neuroprene™ soft supports are a convenient, ... proprioceptive taping for common orthopedic conditions/instabilities. ... provide specific compression and lateral to ... (proprioceptors) in the skin and soft ...
... The Drytex Adjustable Patella Donut ... a unique nylon core and polyester ... airflow. A trimable full-circumference donut provides ... who have neoprene based allergies or ...
... for total knees, meniscus repairs, regenerative chondroplasty, ... TROM gives easy-to-use range of motion control ... Rehab TROM can be used as a ... purchased separately be used with the TROM ...
Medicine Products: